Novel Antimicrobial Technology
Photopharmica has pioneered a photodynamic therapy-based approach (P-PAT) for the prevention and treatment of localised infections.
P-PAT can be applied to dermatology, wound care and for the treatment of antibiotic resistant microorganisms.
- Clinical evidence of efficacy
- Will not induce resistance
- Is effective against all microorganisms including antibiotic resistant microorganisms
- Readily applicable for local therapy
- Rapid treatment
- Pain free
- NEWS
- January 2013 - Photopharmica appoints Nigel Crockett as Commercial Advisor.
- January 2013 - Photopharmica secures investment.
- October 2012 - Professor Stan Brown publishes paper on the clinical use of antimicrobial photodynamic therapy.
- October 2012 - The results of Photopharmica’s first Phase 2 clinical study are published in the British Journal of Dermatology.
The Company is activity seeking corporate partners. Please contact us if you would like further information.
Photopharmica
Telephone: 0870 126 3200
Email: business@photopharmica.com
Registered in England and Wales No. 8315366
Design + Build = www.benrobertson.co.uk
All rights reserved.
Site Map